Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

The lawsuit said that Janssen leadership pushed sales reps to claim that an antiretroviral HIV drug called Prezista would not increase cholesterol for patients and cause cardiovascular issues ...

Social barriers were linked to reduced access and low uptake of LAI PrEP and ART for HIV treatment and prevention.

She says she feels weak and has developed an itchy rash. There are Zambian government clinics that still stock HIV drugs but they've been so overwhelmed by HIV patients from the shuttered U.S ...

Sometimes she's gone up to 14 days with no HIV medication at all. Right now, she has a few pills and has decided to take them every third day. It's risky because her body could develop resistance to ...

The prevalence of hepatitis C virus (HCV) has decreased over time among patients with HIV infection in the United States with the use of direct-acting antiviral (DAA) therapy, according to findings ...

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment. The company ...

Enteroviruses are a group of viruses that cause everything from the common cold to meningitis, polio, type 1 diabetes, and ...

Dual Trials Accelerate VELDONA® Toward Rare Disease Market EntryBridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc. (N ...

Physicians and their patients report that engagement in an HIV-based community rivals drug effectiveness in the ongoing efforts to curtail an epidemic. Confronting the HIV Epidemic: There's an App ...